Zonisamide for partial-onset seizures in children
Part of Brain & nervous system clinical trials.
This study tests a liquid form of the seizure medicine zonisamide in children aged 1 month to 17 years. It aims to see how the medicine works in the body and whether it is safe and well-tolerated for controlling partial-onset seizures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 month and 17 years old.
- Your child must have partial-onset (focal) seizures, which start in one part of the brain.
- Your child must have had more than one seizure in the last 3 months (or more than two in the last 6 months).
- Your child must be on a stable dose of their current seizure medication for at least 30 days before starting the study.
- Your child must not have had kidney stones or be prone to them, and must not have taken zonisamide before.
- Your child must be generally healthy, with normal blood test results for liver and kidney function, and if female and of childbearing age, must use birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding zonisamide to the current epilepsy medication for children aged 1 to 14 who still have focal seizures. The goal is to see if the combination works better and is safe.
This trial tests an oral cannabidiol medicine (Epidiolex) for children whose seizures are not controlled by other treatments. It aims to see if adding this drug can reduce seizure frequency.
This trial studies the best dose of a seizure medicine for children who are actively seizing while emergency medical teams are treating them. It may help EMS crews give safer, more effective treatment during transport.
This study looks at what causes certain serious seizures that start early in life, and how to treat them. It may help doctors better match treatments to the seizure cause in newborns and young infants.
This study tests a new seizure medication called ONO-2017 in Japanese children and teenagers (ages 2–17) who have a specific type of seizure called POS that hasn't been controlled by current medicines. The goal is to see if this new drug is safe and helps reduce these seizures.
This study tests a medication called eslicarbazepine for adults who have partial-onset seizures. It may help people who are newly diagnosed or who have not had good results with two common seizure medicines, carbamazepine or oxcarbazepine.
Hear when a new Seizures trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.